<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39458327</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>New Insights into the Epidemiological Characteristics of <i>Mycoplasma pneumoniae</i> Infection before and after the COVID-19 Pandemic.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2019</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12102019</ELocationID><Abstract><AbstractText><i>Mycoplasma pneumoniae</i> (<i>M. pneumoniae</i>), a prevalent respiratory pathogen affecting children and adolescents, is known to trigger periodic global epidemics. The most recent significant outbreak commenced in the first half of 2023 and reached its peak globally during the autumn and winter months. Considering the worldwide repercussions of the COVID-19 pandemic, it has become increasingly essential to delve into the epidemiological characteristics of <i>M. pneumoniae</i> both before and after the pandemic. This review aims to provide a comprehensive analysis of the key features of <i>M. pneumoniae</i> epidemics in the pre-and post-COVID-19 contexts, including but not limited to shifts in the susceptible population, the molecular genotypes of the pathogen, the clinical manifestations, and potential new trends in drug resistance. Additionally, we will introduce the latest advancements in the diagnosis of <i>M. pneumoniae</i>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qianyue</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Clinical Lab in Children's Hospital of Shanghai, Children's Hospital of Shanghai Jiao Tong University, Shanghai 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Xiaozhou</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Lab in Children's Hospital of Shanghai, Children's Hospital of Shanghai Jiao Tong University, Shanghai 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Dingding</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Lab in Children's Hospital of Shanghai, Children's Hospital of Shanghai Jiao Tong University, Shanghai 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Zhan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Clinical Lab in Children's Hospital of Shanghai, Children's Hospital of Shanghai Jiao Tong University, Shanghai 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Lab in Children's Hospital of Shanghai, Children's Hospital of Shanghai Jiao Tong University, Shanghai 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword><Keyword MajorTopicYN="N">epidemiological</Keyword><Keyword MajorTopicYN="N">genotypes</Keyword><Keyword MajorTopicYN="N">macrolide resistance</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39458327</ArticleId><ArticleId IdType="pmc">PMC11509874</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12102019</ArticleId><ArticleId IdType="pii">microorganisms12102019</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Waites K.B., Xiao L., Liu Y., Balish M.F., Atkinson T.P. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin. Microbiol. Rev. 2017;30:747–809. doi: 10.1128/CMR.00114-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00114-16</ArticleId><ArticleId IdType="pmc">PMC5475226</ArticleId><ArticleId IdType="pubmed">28539503</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur P.M., Unger W.W.J., Nadal D., Berger C., Vink C., Van Rossum A.M.C. Infection with and Carriage of Mycoplasma Pneumoniae in Children. Front. Microbiol. 2016;7:329. doi: 10.3389/fmicb.2016.00329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00329</ArticleId><ArticleId IdType="pmc">PMC4803743</ArticleId><ArticleId IdType="pubmed">27047456</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrott G.L., Kinjo T., Fujita J. A Compendium for Mycoplasma pneumoniae. Front. Microbiol. 2016;7:513. doi: 10.3389/fmicb.2016.00513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00513</ArticleId><ArticleId IdType="pmc">PMC4828434</ArticleId><ArticleId IdType="pubmed">27148202</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L., Huang S., Zheng C., Zhang Y., Chen Z. Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management. J. Clin. Med. 2022;11:2824. doi: 10.3390/jcm11102824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11102824</ArticleId><ArticleId IdType="pmc">PMC9144103</ArticleId><ArticleId IdType="pubmed">35628949</ArticleId></ArticleIdList></Reference><Reference><Citation>Morozumi M., Ubukata K., Takahashi T. Macrolide-Resistant Mycoplasma pneumoniae: Characteristics of Isolates and Clinical Aspects of Community-Acquired Pneumonia. J. Infect. Chemother. 2010;16:78–86. doi: 10.1007/s10156-009-0021-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10156-009-0021-4</ArticleId><ArticleId IdType="pubmed">20094751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H.-J., Song D.J., Shim J.Y. Mechanism of Resistance Acquisition and Treatment of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children. Korean J. Pediatr. 2017;60:167–174. doi: 10.3345/kjp.2017.60.6.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2017.60.6.167</ArticleId><ArticleId IdType="pmc">PMC5500384</ArticleId><ArticleId IdType="pubmed">28690643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K., Jung S., Kim M., Park S., Yang H.-J., Lee E. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-Analysis. JAMA Netw. Open. 2022;5:e2220949. doi: 10.1001/jamanetworkopen.2022.20949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.20949</ArticleId><ArticleId IdType="pmc">PMC9274321</ArticleId><ArticleId IdType="pubmed">35816304</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.J., Holden M.T.G., Spiller O.B., Chalker V.J. Development of a Multilocus Sequence Typing Scheme for Molecular Typing of Mycoplasma pneumoniae. J. Clin. Microbiol. 2015;53:3195–3203. doi: 10.1128/JCM.01301-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01301-15</ArticleId><ArticleId IdType="pmc">PMC4572520</ArticleId><ArticleId IdType="pubmed">26202118</ArticleId></ArticleIdList></Reference><Reference><Citation>Touati A., Blouin Y., Sirand-Pugnet P., Renaudin H., Oishi T., Vergnaud G., Bébéar C., Pereyre S. Molecular Epidemiology of Mycoplasma pneumoniae: Genotyping Using Single Nucleotide Polymorphisms and SNaPshot Technology. J. Clin. Microbiol. 2015;53:3182–3194. doi: 10.1128/JCM.01156-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01156-15</ArticleId><ArticleId IdType="pmc">PMC4572556</ArticleId><ArticleId IdType="pubmed">26202117</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Xu B., Wu X., Yin Q., Wang Y., Li J., Jiao W., Quan S., Sun L., Wang Y., et al. Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated with Macrolide Usage and Genotype Shifting. Front. Cell. Infect. Microbiol. 2021;11:675466. doi: 10.3389/fcimb.2021.675466.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.675466</ArticleId><ArticleId IdType="pmc">PMC8149950</ArticleId><ArticleId IdType="pubmed">34055671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenri T., Okazaki N., Yamazaki T., Narita M., Izumikawa K., Matsuoka M., Suzuki S., Horino A., Sasaki T. Genotyping Analysis of Mycoplasma pneumoniae Clinical Strains in Japan between 1995 and 2005: Type Shift Phenomenon of M. pneumoniae Clinical Strains. J. Med. Microbiol. 2008;57:469–475. doi: 10.1099/jmm.0.47634-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.47634-0</ArticleId><ArticleId IdType="pubmed">18349367</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H.-M., Chuang C.-H., Chen Y.-Y., Liao W.-C., Li S.-W., Chang I.Y.-F., Chen C.-H., Li T.-H., Huang Y.-Y., Huang Y.-C., et al. Clonal Spread of Macrolide-Resistant Mycoplasma pneumoniae Sequence Type-3 and Type-17 with Recombination on Non-P1 Adhesin among Children in Taiwan. Clin. Microbiol. Infect. 2021;27:1169.e1–1169.e6. doi: 10.1016/j.cmi.2020.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.035</ArticleId><ArticleId IdType="pubmed">33010445</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C., Sun H., Zhao H. Latest Surveillance Data on Mycoplasma pneumoniae Infections in Children, Suggesting a New Epidemic Occurring in Beijing. J. Clin. Microbiol. 2016;54:1400–1401. doi: 10.1128/JCM.00184-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00184-16</ArticleId><ArticleId IdType="pmc">PMC4844719</ArticleId><ArticleId IdType="pubmed">26912752</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind K., Benzon M.W., Jensen J.S., Clyde W.A., Jr. A Seroepidemiological Study of Mycoplasma pneumoniae Infections in Denmark over the 50-Year Period 1946–1995. Eur. J. Epidemiol. 1997;13:581–586. doi: 10.1023/A:1007353121693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1007353121693</ArticleId><ArticleId IdType="pubmed">9258572</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs E. Mycoplasma pneumoniae: Now in the Focus of Clinicians and Epidemiologists. Eurosurveillance. 2012;17:20084. doi: 10.2807/ese.17.06.20084-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.17.06.20084-en</ArticleId><ArticleId IdType="pubmed">22340972</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson T.P., Balish M.F., Waites K.B. Epidemiology, Clinical Manifestations, Pathogenesis and Laboratory Detection of Mycoplasma pneumoniae Infections: Figure 1. FEMS Microbiol. Rev. 2008;32:956–973. doi: 10.1111/j.1574-6976.2008.00129.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2008.00129.x</ArticleId><ArticleId IdType="pubmed">18754792</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur P.M., Beeton M.L., Uldum S.A., Bossuyt N., Vermeulen M., Loens K., Pereyre S., Bébéar C., Keše D., Day J., et al. Mycoplasma pneumoniae Detections before and during the COVID-19 Pandemic: Results of a Global Survey, 2017 to 2021. Eurosurveillance. 2022;27:2100746. doi: 10.2807/1560-7917.ES.2022.27.19.2100746.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.19.2100746</ArticleId><ArticleId IdType="pmc">PMC9101966</ArticleId><ArticleId IdType="pubmed">35551702</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur P.M., Beeton M.L., European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group Mycoplasma pneumoniae: Delayed Re-Emergence after COVID-19 Pandemic Restrictions. Lancet Microbe. 2024;5:e100–e101. doi: 10.1016/S2666-5247(23)00344-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00344-0</ArticleId><ArticleId IdType="pubmed">38008103</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender R.G., Sirota S.B., Swetschinski L.R., Dominguez R.-M.V., Novotney A., E Wool E., Ikuta K.S., Vongpradith A., Rogowski E.L.B., Doxey M., et al. GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators Global, Regional, and National Incidence and Mortality Burden of Non-COVID-19 Lower Respiratory Infections and Aetiologies, 1990–2021: A Systematic Analysis from the Global Burden of Disease Study 2021. Lancet Infect. Dis. 2024;24:974–1002. doi: 10.1016/S1473-3099(24)00176-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(24)00176-2</ArticleId><ArticleId IdType="pmc">PMC11339187</ArticleId><ArticleId IdType="pubmed">38636536</ArticleId></ArticleIdList></Reference><Reference><Citation>New Insights in the Outbreak Pattern of Mycoplasma pneumoniae. Int. J. Med. Microbiol. 2015;305:705–708. doi: 10.1016/j.ijmm.2015.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmm.2015.08.021</ArticleId><ArticleId IdType="pubmed">26319941</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeton M.L., Zhang X.-S., Uldum S.A., Bébéar C., Dumke R., Gullsby K., Ieven M., Loens K., Nir-Paz R., Pereyre S., et al. Mycoplasma pneumoniae Infections, 11 Countries in Europe and Israel, 2011 to 2016. Eurosurveillance. 2020;25:1900112. doi: 10.2807/1560-7917.ES.2020.25.2.1900112.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.2.1900112</ArticleId><ArticleId IdType="pmc">PMC6976882</ArticleId><ArticleId IdType="pubmed">31964459</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T., Kenri T. Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae. Front. Microbiol. 2016;7:693. doi: 10.3389/fmicb.2016.00693.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00693</ArticleId><ArticleId IdType="pmc">PMC4876131</ArticleId><ArticleId IdType="pubmed">27242718</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue G., Li M., Wang N., Zhao J., Wang B., Ren Z., Yan C., Wu C., Liu Y., Sun H., et al. Comparison of the Molecular Characteristics of Mycoplasma pneumoniae from Children across Different Regions of China. PLoS ONE. 2018;13:e0198557. doi: 10.1371/journal.pone.0198557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198557</ArticleId><ArticleId IdType="pmc">PMC6107135</ArticleId><ArticleId IdType="pubmed">30138360</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Cheng Y., Dai S., Hou D., Ge M., Zhang Y., Fan L., Pei Y., Yu L., Xue G., et al. The Prevalence of Mycoplasma pneumoniae among Children in Beijing before and during the COVID-19 Pandemic. Front. Cell. Infect. Microbiol. 2022;12:4505. doi: 10.3389/fcimb.2022.854505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.854505</ArticleId><ArticleId IdType="pmc">PMC9103471</ArticleId><ArticleId IdType="pubmed">35573799</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai F., Shou X., Ye Q. Epidemiological Study on Mycoplasma pneumoniae and Chlamydia pneumoniae Infection of Hospitalized Children in a Single Center During the COVID-19 Pandemic. Front. Cell. Infect. Microbiol. 2022;12:843463. doi: 10.3389/fcimb.2022.843463.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.843463</ArticleId><ArticleId IdType="pmc">PMC8977740</ArticleId><ArticleId IdType="pubmed">35386684</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur P.M., Beeton M.L., ESGMAC the ESGMAC MAPS study group Mycoplasma pneumoniae: Gone Forever? Lancet Microbe. 2023;4:e763. doi: 10.1016/S2666-5247(23)00182-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00182-9</ArticleId><ArticleId IdType="pubmed">37393927</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur P.M., Chalker V.J., Berger C., Nir-Paz R., Beeton M.L., ESGMAC and the ESGMAC–MyCOVID study group Mycoplasma pneumoniae beyond the COVID-19 Pandemic: Where Is It? Lancet Microbe. 2022;3:e897. doi: 10.1016/S2666-5247(22)00190-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00190-2</ArticleId><ArticleId IdType="pmc">PMC9371584</ArticleId><ArticleId IdType="pubmed">35964636</ArticleId></ArticleIdList></Reference><Reference><Citation>Upsurge of Respiratory Illnesses among Children-Northern China.  [(accessed on 11 April 2024)].  Available online:  https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON494.</Citation></Reference><Reference><Citation>Xu Y., Yang C., Sun P., Zeng F., Wang Q., Wu J., Fang C., Zhang C., Wang J., Gu Y., et al. Epidemic Features and Megagenomic Analysis of Childhood Mycoplasma pneumoniae Post COVID-19 Pandemic: A 6-Year Study in Southern China. Emerg. Microbes Infect. 2024;13:2353298. doi: 10.1080/22221751.2024.2353298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2024.2353298</ArticleId><ArticleId IdType="pmc">PMC11212572</ArticleId><ArticleId IdType="pubmed">38721691</ArticleId></ArticleIdList></Reference><Reference><Citation>Communicable Disease Threats Report.  [(accessed on 8 December 2023)].  Available online:  https://www.ecdc.europa.eu/sites/default/files/documents/communicable-disease-threats-report-week-49-2023.pdf.</Citation></Reference><Reference><Citation>Meyer Sauteur P.M., Beeton M.L., European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group Pneumonia Outbreaks Due to Re-Emergence of Mycoplasma pneumoniae. Lancet Microbe. 2024;5:e514. doi: 10.1016/S2666-5247(23)00406-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00406-8</ArticleId><ArticleId IdType="pubmed">38342111</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C., Xue G.-H., Zhao H.-Q., Feng Y.-L., Cui J.-H., Yuan J. Current Status of Mycoplasma pneumoniae Infection in China. World J. Pediatr. 2024;20:1–4. doi: 10.1007/s12519-023-00783-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-023-00783-x</ArticleId><ArticleId IdType="pmc">PMC10827902</ArticleId><ArticleId IdType="pubmed">38185707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyi D., Xiao Y., Wang X., Feng S., Wang Y., Liao L., Wang S., Deng Y., Zheng J., Zhao D. Predominance of A2063G Mutant Strains in the Mycoplasma pneumoniae Epidemic in Children-a Clinical and Epidemiological Study in 2023 in Wuhan, China. Int. J. Infect. Dis. 2024;145:107074. doi: 10.1016/j.ijid.2024.107074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2024.107074</ArticleId><ArticleId IdType="pubmed">38734057</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong C., Huang F., Suo L., Guan X., Kang L., Xie H., Hu G., Yang P., Wang Q. Increase of Respiratory Illnesses among Children in Beijing, China, during the Autumn and Winter of 2023. Eurosurveillance. 2024;29:2300704. doi: 10.2807/1560-7917.ES.2024.29.2.2300704.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2024.29.2.2300704</ArticleId><ArticleId IdType="pmc">PMC10785205</ArticleId><ArticleId IdType="pubmed">38214078</ArticleId></ArticleIdList></Reference><Reference><Citation>Edouard S., Boughammoura H., Colson P., La Scola B., Fournier P.-E., Fenollar F. Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023–2024. Emerg. Infect. Dis. 2024;30:1481–1484. doi: 10.3201/eid3007.240315.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid3007.240315</ArticleId><ArticleId IdType="pmc">PMC11210650</ArticleId><ArticleId IdType="pubmed">38816344</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens C., Clopper B.R., DeVies J., Benitez A., McKeever E.R., Johns D., Wolff B., Selvarangan R., Schuster J.E., Weinberg G.A., et al. Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents after the COVID-19 Pandemic, United States, 2018–2024. MMWR Morb. Mortal. Wkly. Rep. 2024;73:149–151. doi: 10.15585/mmwr.mm7307a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7307a3</ArticleId><ArticleId IdType="pmc">PMC10899077</ArticleId><ArticleId IdType="pubmed">38386615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.-B., He W., Gui Y.-H., Lu Q., Yin Y., Zhang J.-H., Dong X.-Y., Wang Y.-W., Ye Y.-Z., Xu H., et al. Current Mycoplasma pneumoniae Epidemic among Children in Shanghai: Unusual Pneumonia Caused by Usual Pathogen. World J. Pediatr. 2024;20:5–10. doi: 10.1007/s12519-023-00793-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-023-00793-9</ArticleId><ArticleId IdType="pubmed">38231466</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.K., Lee T., Kim Y.-J., Kim D.R., Shin A., Kang H.M., Kim Y.J., Kim D.H., Eun B.W., Choe Y.J., et al. Clinical Manifestations, Macrolide Resistance, and Treatment Utilization Trends of Mycoplasma pneumoniae Pneumonia in Children and Adolescents in South Korea. Microorganisms. 2024;12:1806. doi: 10.3390/microorganisms12091806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms12091806</ArticleId><ArticleId IdType="pmc">PMC11434231</ArticleId><ArticleId IdType="pubmed">39338480</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S., Self W.H., Wunderink R.G., Fakhran S., Balk R., Bramley A.M., Chappell J.D. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N. Engl. J. Med. 2015;373:415–427. doi: 10.1056/NEJMoa1500245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1500245</ArticleId><ArticleId IdType="pmc">PMC4728150</ArticleId><ArticleId IdType="pubmed">26172429</ArticleId></ArticleIdList></Reference><Reference><Citation>Waites K.B., Ratliff A., Crabb D.M., Xiao L., Qin X., Selvarangan R., Tang Y.-W., Zheng X., Dien Bard J., Hong T., et al. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. J. Clin. Microbiol. 2019;57:e00968-19. doi: 10.1128/JCM.00968-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00968-19</ArticleId><ArticleId IdType="pmc">PMC6813023</ArticleId><ArticleId IdType="pubmed">31484701</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordholm A.C., Søborg B., Jokelainen P., Lauenborg Møller K., Flink Sørensen L., Grove Krause T., Anker Uldum S., Emborg H.-D. Mycoplasma pneumoniae Epidemic in Denmark, October to December, 2023. Eurosurveillance. 2024;29:2300707. doi: 10.2807/1560-7917.ES.2024.29.2.2300707.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2024.29.2.2300707</ArticleId><ArticleId IdType="pmc">PMC10785206</ArticleId><ArticleId IdType="pubmed">38214084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenri T., Suzuki M., Sekizuka T., Ohya H., Oda Y., Yamazaki T., Fujii H., Hashimoto T., Nakajima H., Katsukawa C., et al. Periodic Genotype Shifts in Clinically Prevalent Mycoplasma pneumoniae Strains in Japan. Front. Cell. Infect. Microbiol. 2020;10:385. doi: 10.3389/fcimb.2020.00385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00385</ArticleId><ArticleId IdType="pmc">PMC7424021</ArticleId><ArticleId IdType="pubmed">32850484</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N., Zhang H., Yin Y., Xu X., Xiao L., Liu Y. Antimicrobial Susceptibility Profiles and Genetic Characteristics of Mycoplasma pneumoniae in Shanghai, China, from 2017 to 2019. Infect. Drug Resist. 2022;15:4443–4452. doi: 10.2147/IDR.S370126.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S370126</ArticleId><ArticleId IdType="pmc">PMC9379117</ArticleId><ArticleId IdType="pubmed">35983294</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Li M., Luo M., Luo Q., Kang L., Xie H., Wang Y., Yu X., Li A., Dong M., et al. Mycoplasma pneumoniae Triggers Pneumonia Epidemic in Autumn and Winter in Beijing: A Multicentre, Population-Based Epidemiological Study between 2015 and 2020. Emerg. Microbes Infect. 2022;11:1508–1517. doi: 10.1080/22221751.2022.2078228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2078228</ArticleId><ArticleId IdType="pmc">PMC9176688</ArticleId><ArticleId IdType="pubmed">35582916</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Li X., Fu Y., Yu Y., Zhou H. Whole-Genome Sequencing Unveils the Outbreak of Mycoplasma pneumoniae in Mainland China. Lancet Microbe. 2024;5:100870. doi: 10.1016/S2666-5247(24)00086-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(24)00086-7</ArticleId><ArticleId IdType="pubmed">38642565</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M., Li Y., Shi Y., Liu H., Tong X., Ma L., Gao J., Du Q., Du H., Liu D., et al. Molecular Epidemiology of Mycoplasma pneumoniae Pneumonia in Children, Wuhan, 2020–2022. BMC Microbiol. 2024;24:23. doi: 10.1186/s12866-024-03180-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-024-03180-0</ArticleId><ArticleId IdType="pmc">PMC10792977</ArticleId><ArticleId IdType="pubmed">38229068</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T.-T., Sun L., Wang T.-Y., Qi H., Tang H., Wang Y.-C., Han Q., Shi X.-Q., Bi J., Jiao W.-W., et al. The Clinical Significance of Macrolide Resistance in Pediatric Mycoplasma pneumoniae Infection during COVID-19 Pandemic. Front. Cell. Infect. Microbiol. 2023;13:1181402. doi: 10.3389/fcimb.2023.1181402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1181402</ArticleId><ArticleId IdType="pmc">PMC10213390</ArticleId><ArticleId IdType="pubmed">37249975</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.-C., Hsueh C.-C., Hsu C.-K., Tsai Y.-W., Hsueh P.-R. Disease Burden and Macrolide Resistance of Mycoplasma pneumoniae Infection in Adults in Asia-Pacific Region. Int. J. Antimicrob. Agents. 2024;64:107205. doi: 10.1016/j.ijantimicag.2024.107205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2024.107205</ArticleId><ArticleId IdType="pubmed">38754527</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng M., Yang J., Zhou J. The Molecular Characteristics, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae in Children. Front. Pediatr. 2023;11:1115009. doi: 10.3389/fped.2023.1115009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1115009</ArticleId><ArticleId IdType="pmc">PMC10017863</ArticleId><ArticleId IdType="pubmed">36937963</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Li S., Yang H., Chen Z., Zhou Z. Resurgence of Mycoplasma pneumonia by Macrolide-Resistant Epidemic Clones in China. Lancet Microbe. 2024;5:e515. doi: 10.1016/S2666-5247(23)00405-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00405-6</ArticleId><ArticleId IdType="pubmed">38244553</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva A., Siccardi G., Migliarini A., Cancelli F., Carnevalini M., D’Andria M., Attilia I., Danese V.C., Cecchetti V., Romiti R., et al. Co-Infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: A Case Series and Review of the Literature. Infection. 2020;48:871–877. doi: 10.1007/s15010-020-01483-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01483-8</ArticleId><ArticleId IdType="pmc">PMC7386385</ArticleId><ArticleId IdType="pubmed">32725598</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayam V., Konala V.M., Naramala S., Garlapati P.R., Merghani M.A., Regmi N., Balla M., Adapa S. Presenting Characteristics, Comorbidities, and Outcomes of Patients Coinfected with COVID-19 and Mycoplasma pneumoniae in the USA. J. Med. Virol. 2020;92:2181–2187. doi: 10.1002/jmv.26026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26026</ArticleId><ArticleId IdType="pmc">PMC7280653</ArticleId><ArticleId IdType="pubmed">32449972</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Q., Li G., Xing Y., Chen T., Li W., Ni W., Deng K., Gao R., Chen C., Gao Y., et al. Precautions Are Needed for COVID-19 Patients with Coinfection of Common Respiratory Pathogens. MedRxiv. 2002:20027698. doi: 10.2139/ssrn.3550013.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3550013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Xing Y., Shi L., Li W., Gao Y., Pan S., Wang Y., Wang W., Xing Q. Coinfection and Other Clinical Characteristics of COVID-19 in Children. Pediatrics. 2020;146:e20200961. doi: 10.1542/peds.2020-0961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0961</ArticleId><ArticleId IdType="pubmed">32376725</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarino M., Perna B., Cuoghi F., Spampinato M.D., Cesaro A.E., Manza F., Pretula A., Grilli A., Maritati M., Caio G., et al. Role of Intracellular Pulmonary Pathogens during SARS-CoV-2 Infection in the First Pandemic Wave of COVID-19: Clinical and Prognostic Significance in a Case Series of 1200 Patients. Microorganisms. 2022;10:1636. doi: 10.3390/microorganisms10081636.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10081636</ArticleId><ArticleId IdType="pmc">PMC9412488</ArticleId><ArticleId IdType="pubmed">36014055</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha L., Shen J., Tefsen B., Wang Y., Lu W., Xu Q. Clinical Features and Outcomes of Adult COVID-19 Patients Co-Infected with Mycoplasma pneumoniae. J. Infect. 2020;81:e12–e15. doi: 10.1016/j.jinf.2020.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.07.010</ArticleId><ArticleId IdType="pmc">PMC7342079</ArticleId><ArticleId IdType="pubmed">32652163</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Mao J., Chen G., Huang Y., Zhou J., Gao C., Jin D., Zhang C., Wen J., Sun J. Evaluation on Blood Coagulation and C-Reactive Protein Level among Children with Mycoplasma pneumoniae Pneumonia by Different Chest Imaging Findings. Medicine. 2021;100:e23926. doi: 10.1097/MD.0000000000023926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000023926</ArticleId><ArticleId IdType="pmc">PMC7837868</ArticleId><ArticleId IdType="pubmed">33545964</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X.Q., Luo J., Wang C.J., Luo Z.X., Tian D.Y., Xie X.H. Clinical Features of Severe Mycoplasma pneumoniae Pneumonia with Pulmonary Complications in Childhood: A Retrospective Study. Pediatr. Pulmonol. 2023;58:2815–2822. doi: 10.1002/ppul.26593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26593</ArticleId><ArticleId IdType="pubmed">37431970</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Ke S., Vinturache A., Dong X., Ding G. Pulmonary Embolism Associated with Mycoplasma pneumoniae Pneumonia in Children. Pediatr. Pulmonol. 2023;58:3605–3608. doi: 10.1002/ppul.26691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26691</ArticleId><ArticleId IdType="pubmed">37701933</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of the People’s Republic of China . Guidelines for the Diagnosis and Treatment of Mycoplasma pneumoniae Pneumonia in Children. 2023rd ed. National Health Commission of the People’s Republic of China; Beijing, China: 2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn331340-20230217-00023</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Lu S., Guo Y., Luan W., Liu J., Wang L. A Comparative Study of General and Severe Mycoplasma pneumoniae Pneumonia in Children. BMC Infect. Dis. 2024;24:449. doi: 10.1186/s12879-024-09340-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09340-x</ArticleId><ArticleId IdType="pmc">PMC11046970</ArticleId><ArticleId IdType="pubmed">38671341</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson T.P., Waites K.B. Mycoplasma pneumoniae Infections in Childhood. Pediatr. Infect. Dis. J. 2014;33:92–94. doi: 10.1097/INF.0000000000000171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000000171</ArticleId><ArticleId IdType="pubmed">24346598</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L.-W., Yin J., Hu Y., Liu X., Feng X., He J.-X., Liu J., Guo Y., Xu B.-P., Shen K.-L. The Epidemiology of Paediatric Mycoplasma pneumoniae Pneumonia in North China: 2006 to 2016. Epidemiol. Infect. 2019;147:e192. doi: 10.1017/S0950268819000839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268819000839</ArticleId><ArticleId IdType="pmc">PMC6518602</ArticleId><ArticleId IdType="pubmed">31364532</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutty P.K., Jain S., Taylor T.H., Bramley A.M., Diaz M.H., Ampofo K., Arnold S.R., Williams D.J., Edwards K.M., McCullers J.A., et al. Mycoplasma pneumoniae among Children Hospitalized with Community-Acquired Pneumonia. Clin. Infect. Dis. 2019;68:5–12. doi: 10.1093/cid/ciy419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy419</ArticleId><ArticleId IdType="pmc">PMC6552676</ArticleId><ArticleId IdType="pubmed">29788037</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses in Individuals Recovering from COVID-19 with and without Post-Acute Symptoms. Cell Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-Term Perturbation of the Peripheral Immune System Months after SARS-CoV-2 Infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumikawa K. Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia. Front. Microbiol. 2016;7:800. doi: 10.3389/fmicb.2016.00800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00800</ArticleId><ArticleId IdType="pmc">PMC4888638</ArticleId><ArticleId IdType="pubmed">27313568</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury T., Sviri S., Rmeileh A.A., Nubani A., Abutbul A., Hoss S., Van Heerden P.V., Bayya A.E., Hidalgo-Grass C., Moses A.E., et al. Increased Rates of Intensive Care Unit Admission in Patients with Mycoplasma pneumoniae: A Retrospective Study. Clin. Microbiol. Infect. 2016;22:711–714. doi: 10.1016/j.cmi.2016.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2016.05.028</ArticleId><ArticleId IdType="pubmed">27297319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolluyt D.C., Euser S.M., Souverein D., van Rossum A.M., Kalpoe J., van Westreenen M., Goeijenbier M., Snijders D., Eggink D., Jongenotter F., et al. Increased Incidence of Mycoplasma pneumoniae Infections and Hospital Admissions in the Netherlands, November to December 2023. Eurosurveillance. 2024;29:2300724. doi: 10.2807/1560-7917.ES.2024.29.4.2300724.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2024.29.4.2300724</ArticleId><ArticleId IdType="pmc">PMC10986650</ArticleId><ArticleId IdType="pubmed">38275014</ArticleId></ArticleIdList></Reference><Reference><Citation>Larcher R., Boudet A., Roger C., Villa F., Loubet P. Mycoplasma pneumoniae Is Back! Is It the next Pandemic? Anaesth. Crit. Care Pain. Med. 2024;43:101338. doi: 10.1016/j.accpm.2023.101338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2023.101338</ArticleId><ArticleId IdType="pubmed">38072068</ArticleId></ArticleIdList></Reference><Reference><Citation>Garzoni C., Bernasconi E., Zehnder C., Malossa S.F., Merlani G., Bongiovanni M. Re: Unexpected Increase of Severe Mycoplasma pneumoniae Pneumonia in Adults in Southern Switzerland. Clin. Microbiol. Infect. 2024;30:953–954. doi: 10.1016/j.cmi.2024.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2024.05.005</ArticleId><ArticleId IdType="pubmed">38461940</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan B.E., Lim K.G.E., Chong V.C.L., Chan S.S.W., Ong K.H., Kuperan P. COVID-19 and Mycoplasma pneumoniae Coinfection. Am. J. Hematol. 2020;95:723–724. doi: 10.1002/ajh.25785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25785</ArticleId><ArticleId IdType="pmc">PMC7227380</ArticleId><ArticleId IdType="pubmed">32173883</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-R., Zou H., Xue M., Chen Z.-B., Chen W.-X. A Case of Childhood COVID-19 Infection with Pleural Effusion Complicated by Possible Secondary Mycoplasma pneumoniae Infection. Pediatr. Infect. Dis. J. 2020;39:e135. doi: 10.1097/INF.0000000000002721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002721</ArticleId><ArticleId IdType="pmc">PMC7359899</ArticleId><ArticleId IdType="pubmed">32379193</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Gao L., Chen X., Xu Y. A 49-Year-Old Woman Co-Infected with SARS-COV-2 and Mycoplasma—A Case Report 2020. World J. Clin. Cases. 2020;8:6080. doi: 10.12998/wjcc.v8.i23.6080.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v8.i23.6080</ArticleId><ArticleId IdType="pmc">PMC7723715</ArticleId><ArticleId IdType="pubmed">33344608</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S., Poloni S., Plantin J., Hamani A., Meckert Y., Lavoignet C.-E., Gendrin V., Klopfenstein T. Outbreak of Mycoplasma pneumoniae Pneumonia in Hospitalized Patients: Who Is Concerned? Nord Franche-Comté Hospital, France, 2023–2024. Epidemiol. Infect. 2024;152:e46. doi: 10.1017/S0950268824000281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268824000281</ArticleId><ArticleId IdType="pmc">PMC10983049</ArticleId><ArticleId IdType="pubmed">38356388</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing F.-F., Chiu K.H.-Y., Deng C.-W., Ye H.-Y., Sun L.-L., Su Y.-X., Cai H.-J., Lo S.K.-F., Rong L., Chen J.-L., et al. Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Mycoplasma pneumoniae Infection: A Descriptive Study. Antibiotics. 2024;13:262. doi: 10.3390/antibiotics13030262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics13030262</ArticleId><ArticleId IdType="pmc">PMC10967482</ArticleId><ArticleId IdType="pubmed">38534697</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurman K.A., Walter N.D., Schwartz S.B., Mitchell S.L., Dillon M.T., Baughman A.L., Deutscher M., Fulton J.P., Tongren J.E., Hicks L.A., et al. Comparison of Laboratory Diagnostic Procedures for Detection of Mycoplasma pneumoniae in Community Outbreaks. Clin. Infect. Dis. 2009;48:1244–1249. doi: 10.1086/597775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/597775</ArticleId><ArticleId IdType="pubmed">19331586</ArticleId></ArticleIdList></Reference><Reference><Citation>Loens K., Ieven M. Mycoplasma pneumoniae: Current Knowledge on Nucleic Acid Amplification Techniques and Serological Diagnostics. Front. Microbiol. 2016;7:448. doi: 10.3389/fmicb.2016.00448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00448</ArticleId><ArticleId IdType="pmc">PMC4814781</ArticleId><ArticleId IdType="pubmed">27064893</ArticleId></ArticleIdList></Reference><Reference><Citation>Nir-Paz R., Michael-Gayego A., Ron M., Block C. Evaluation of Eight Commercial Tests for Mycoplasma pneumoniae Antibodies in the Absence of Acute Infection. Clin. Microbiol. Infect. 2006;12:685–688. doi: 10.1111/j.1469-0691.2006.01469.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2006.01469.x</ArticleId><ArticleId IdType="pubmed">16774570</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Xiao L. Overview of the Epidemic Characteristics of Mycoplasma pneumoniae Infection around COVID Pandemic. iLABMED. 2023;1:148–157. doi: 10.1002/ila2.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ila2.27</ArticleId></ArticleIdList></Reference><Reference><Citation>Choo S., Kim S.-H., Lee E. Clinical Significance of Mycoplasma Pneumoniae Specific IgM Titer in Children Hospitalized with Mycoplasma pneumoniae Pneumonia. BMC Infect. Dis. 2022;22:470. doi: 10.1186/s12879-022-07456-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07456-6</ArticleId><ArticleId IdType="pmc">PMC9109195</ArticleId><ArticleId IdType="pubmed">35578177</ArticleId></ArticleIdList></Reference><Reference><Citation>Loens K., Goossens H., Ieven M. Acute Respiratory Infection Due to Mycoplasma pneumoniae: Current Status of Diagnostic Methods. Eur. J. Clin. Microbiol. Infect. Dis. 2010;29:1055–1069. doi: 10.1007/s10096-010-0975-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-010-0975-2</ArticleId><ArticleId IdType="pmc">PMC7088226</ArticleId><ArticleId IdType="pubmed">20526788</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Ma Z., Qin J., Shen Z., Liu Q., Chen X., Wang H., An Z., Liu W., Li M. A Versatile Loop-Mediated Isothermal Amplification Microchip Platform for Streptococcus pneumoniae and Mycoplasma pneumoniae Testing at the Point of Care. Biosens. Bioelectron. 2019;126:373–380. doi: 10.1016/j.bios.2018.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2018.11.011</ArticleId><ArticleId IdType="pubmed">30469075</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R., Jiang H., Li C., Li Y., Peng M., Wang J., Wu Q., Yan C., Bo Q., Wang J., et al. CRISPR/Cas9-Based Point-of-Care Lateral Flow Biosensor with Improved Performance for Rapid and Robust Detection of Mycoplasma pneumonia. Anal. Chim. Acta. 2023;1257:341175. doi: 10.1016/j.aca.2023.341175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2023.341175</ArticleId><ArticleId IdType="pubmed">37062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Zhou J., Sun C., Huang X., Zheng B., Fu J., Jia N., Xu Z., Cui X., Wang Y. Loop-Mediated Isothermal Amplification Coupled with Nanoparticle-Based Biosensor: A Rapid and Sensitive Method to Detect Mycoplasma pneumoniae. Front. Cell. Infect. Microbiol. 2022;12:882855. doi: 10.3389/fcimb.2022.882855.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.882855</ArticleId><ArticleId IdType="pmc">PMC9299420</ArticleId><ArticleId IdType="pubmed">35873146</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wang Y., Jiao W., Li J., Quan S., Sun L., Wang Y., Qi X., Wang X., Shen A. Development of Loop-Mediated Isothermal Amplification Coupled with Nanoparticle-Based Lateral Flow Biosensor Assay for Mycoplasma pneumoniae Detection. AMB Express. 2019;9:196. doi: 10.1186/s13568-019-0921-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13568-019-0921-3</ArticleId><ArticleId IdType="pmc">PMC6895324</ArticleId><ArticleId IdType="pubmed">31807946</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia N., Zhou J., Xiao F., Zheng B., Huang X., Sun C., Fu J., Xu Z., Chen M., Wang Y. A CRISPR-Cas12a-Based Platform for Ultrasensitive, Rapid, and Highly Specific Detection of Mycoplasma pneumonia in Clinical Application. Front. Bioeng. Biotechnol. 2023;11:1022066. doi: 10.3389/fbioe.2023.1022066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2023.1022066</ArticleId><ArticleId IdType="pmc">PMC9887289</ArticleId><ArticleId IdType="pubmed">36733967</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Xiao F., Fu J., Jia N., Huang X., Sun C., Xu Z., Zhang Y., Qu D., Wang Y. Rapid, Ultrasensitive and Highly Specific Diagnosis of Mycoplasma pneumoniae by a CRISPR-Based Detection Platform. Front. Cell. Infect. Microbiol. 2023;13:1147142. doi: 10.3389/fcimb.2023.1147142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1147142</ArticleId><ArticleId IdType="pmc">PMC10414563</ArticleId><ArticleId IdType="pubmed">37577370</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur P.M., Seiler M., Trück J., Unger W.W.J., Paioni P., Relly C., Staubli G., Haas T., Gysin C., Bachmann L.M., et al. Diagnosis of Mycoplasma pneumoniae Pneumonia with Measurement of Specific Antibody-Secreting Cells. Am. J. Respir. Crit. Care Med. 2019;200:1066–1069. doi: 10.1164/rccm.201904-0860LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201904-0860LE</ArticleId><ArticleId IdType="pmc">PMC6794114</ArticleId><ArticleId IdType="pubmed">31251669</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter M.J., Mitchell R.M., Meyer Sauteur P.M., Kelly D.F., Trück J. The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications. Front. Immunol. 2017;8:630. doi: 10.3389/fimmu.2017.00630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00630</ArticleId><ArticleId IdType="pmc">PMC5451496</ArticleId><ArticleId IdType="pubmed">28620385</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur P.M., Trück J., van Rossum A.M.C., Berger C. Circulating Antibody-Secreting Cell Response during Mycoplasma pneumoniae Childhood Pneumonia. J. Infect. Dis. 2020;222:136–147. doi: 10.1093/infdis/jiaa062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa062</ArticleId><ArticleId IdType="pubmed">32034406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai W.-C., Hsieh Y.-C., Chen Y.-C., Kuo C.-Y., Chen C.-J., Huang Y.-C., Chiu C.-H., Lin T.-Y., Huang K.-Y.A. A Potent Antibody-Secreting B Cell Response to Mycoplasma pneumoniae in Children with Pneumonia. J. Microbiol. Immunol. Infect. 2022;55:413–420. doi: 10.1016/j.jmii.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2021.08.010</ArticleId><ArticleId IdType="pubmed">34503921</ArticleId></ArticleIdList></Reference><Reference><Citation>Iseki M., Takahashi T., Kimura K., Yamashita R., Sasaki T. Number of Specific Antibody-Secreting Cells in the Peripheral Blood among Children with Mycoplasma pneumonia. Infect. Immun. 1996;64:2799–2803. doi: 10.1128/iai.64.7.2799-2803.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.64.7.2799-2803.1996</ArticleId><ArticleId IdType="pmc">PMC174142</ArticleId><ArticleId IdType="pubmed">8698511</ArticleId></ArticleIdList></Reference><Reference><Citation>Saletti G., Çuburu N., Yang J.S., Dey A., Czerkinsky C. Enzyme-Linked Immunospot Assays for Direct Ex Vivo Measurement of Vaccine-Induced Human Humoral Immune Responses in Blood. Nat. Protoc. 2013;8:1073–1087. doi: 10.1038/nprot.2013.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.058</ArticleId><ArticleId IdType="pubmed">23660756</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>